BA Tech — SHANGHAI BA TECHNOLOGY CO., LTD.
CASE 01

Cross-Border Licensing of a Phase III AAV Gene Therapy

Territory: Eurasia (EAEU) & Europe

Cross-border licensing of a proprietary Chinese Phase III AAV gene therapy candidate across target EAEU and European jurisdictions, covering bridging clinical trial coordination, clinical material supply, and technology transfer for commercial-scale production.

Business Inquiries

Start a Cross-Border
Biopharma & Biotech Collaboration

Whether you are exploring cross-border pipeline licensing, custom automated bioprocess equipment, or supply chain integration in China, we welcome your inquiry. A managing partner for the relevant practice will respond within 3 business days.

Business Emailcontact@shbatech.com
LocationShanghai, China
Send Business Email